Empowering Practice: Biomarker-Driven Decisions in Metastatic Non–Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. While advances in precision oncology have dramatically improved survival, these benefits rely on comprehensive and timely molecular testing, which remains suboptimal in real-world practice. This complexity, combined with the need to balance efficacy, safety, and cost, creates persistent gaps in consistent biomarker-driven decision-making for all patients. As highly engaged members of the oncology team, physicians, pharmacists, and nurses play a critical role in ensuring timely testing, optimizing therapy selection, and ensuring access to high-quality healthcare for all patients.

This multi-module educational program is designed to bridge these gaps and drive measurable, sustainable practice change through a stewardship lens. The initiative features a first-of-its-kind partnership with the Michigan Oncology Quality Consortium (MOQC), an organization that works to improve quality in cancer care in the state of Michigan. The MOQC Oncology Stewardship program aims to enhance patients’ health outcomes while reducing financial toxicity. This collaborative framework integrates real-world, data-informed insights from MOQC’s statewide network, linking education directly to care delivery outcomes and fostering a unified, evidence-based approach to patient management.

For more information about MOQC, please see section below or go to https://moqc.org/

The activity consists of a series of dynamic modules designed to enhance practical multidisciplinary expertise in mNSCLC.

Join us to update your clinical approach on:

  • The latest advances in biomarker testing
  • Effective frontline treatment decision-making
  • Improving access to biomarker-driven care for all individuals

Please note: The CME/NCPD credit component of this activity is accredited with Physicians' Education Resource. You will be redirected to https://www.gotoper.com/.


About MOQC (https://moqc.org/)

The Michigan Oncology Quality Consortium (MOQC) is a physician-led voluntary collaborative of medical and gynecologic oncologists. Their purpose is to further the success of interdisciplinary teams, improving the quality and value of cancer care. MOQC is sponsored by the Value Partnership Program of Blue Cross Blue Shield of Michigan (BCBSM). They work with community and academic oncologists, nurses, pharmacists, nurse practitioners, physician assistants, medical assistants, abstractors, hospices, and patients and caregivers to identify areas where they can improve quality or value.

MOQC is a BCBSM Collaborative Quality Initiative (CQI). CQIs are partnerships between BCBSM, participating practices, physicians and a coordinating center team. Practices share data to identify and refine processes in areas of cancer care associated with high costs and wide variation. BCBSM never sees individual practice or physician data. The coordinating center uses data collected to identify opportunities for improvement. The coordinating center, in concert with expertise shared in Steering and Measures committees, drive the goals and areas of performance improvement. Both committees include members from MOQC’s Patient and Caregiver Oncology Council (POQC), who act as the representative voice of patients and caregivers. Quality improvement work benefits all patients regardless of insurance coverage. BCBSM believes that if quality is improved, costs will decrease and its members will benefit.

MOQC is transforming cancer care by collaborating with oncology practices to standardize treatments, enhance patient outcomes, and reduce healthcare costs. By leveraging data-driven insights, MOQC helps practices implement evidence-based guidelines, track performance, and adopt continuous quality improvement strategies. As a result, MOQC has driven improvements in patient survival, reduced hospital readmissions, and enhanced patient satisfaction. The consortium's efforts have led to more consistent adherence to treatment protocols and a reduction in care delivery variability. MOQC routinely publishes and presents results of its work and creates pilot projects that other states use as models.